Predict your next investment

Venture Capital
aigorion.com

See what CB Insights has to offer

Investments

3

Portfolio Exits

1

Funds

1

About Orion Fund

The company focuses solely on investments in internet and IT companies.

Orion Fund Headquarter Location

Jerusalem Technology Park Building 98

Jerusalem, 96951,

Israel

972 2 649 0708

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Orion Fund News

Sun Genomics Receives $9.25M Series A

Sep 17, 2020

The round was led by Pangaea Ventures with new investments from Orion Fund, managed by K3 Ventures, and Emerging Technologies Partners. "Among the scientific and general community, the awareness and understanding of the gut microflora's important impact on a person's overall health and well-being is growing rapidly," said MX Kuok, managing partner of K3 Ventures. "We are proud to support Sun Genomics' scientifically rigorous approach to microbiome sequencing and customized probiotics, which has already improved lives in a quantifiable, measurable way." K3 Ventures invests in early-stage and late-stage technology startups with companies such as Palantir, Airbnb, SpaceX, Planet Labs, and TikTok in its portfolio. Sun Genomics will use this round of funding to support its growth in the custom probiotics market, scale delivery across the U.S., enter international markets, and propel the publication of its studies in partnership with leading academic institutions. "Despite the many challenges and setbacks the pandemic has had on businesses and individuals, we're proud of the momentum we've built this year from this new financing, to a prestigious academic collaboration, and the launch of our innovative immunity-health supplement, Floré Defense," said Sunny Jain, CEO and founder of Sun Genomics. In addition to the Series A close, Sun Genomics announces Dr. Jack Gilbert, PhD, as medical and scientific advisor, and Mayank Goel as vice president of growth. At the University of California, San Diego Center of Microbiome Innovation, Dr. Gilbert uses molecular analysis to test fundamental hypotheses in microbial ecology. He has authored more than 250 peer-reviewed publications and book chapters on metagenomics and approaches to ecosystem ecology. Prior to Sun Genomics, Goel led growth marketing and analytics at two successfully acquired travel startups - HotelTonight (acquired by Airbnb) and Pillow (acquired by Vrbo, Expedia Group). He has created data-driven personalized services leading to growing user retention and revenues. Goel brings a unique combination of growth strategy and data analytics to help Sun Genomics become the leader in custom probiotics. Sun Genomics was founded in 2016 with the release of its flagship product Floré, a microbiome test and gut probiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles. As part of its growing line of gut health products, Sun Genomics launched Floré Defense in July 2020, an all-natural formula to boost immunity and respiratory health. "I'm excited to work with the innovative leaders at Sun Genomics as they continue to study and educate consumers and companies on the ecology of the gut microbiome to improve overall health," said Dr. Gilbert, medical and scientific advisor. "Gut testing will soon be standard of care for preventative health and I look forward to collaborating with Sun Genomics as they grow the production of scientifically credible solutions and research." About Sun Genomics Sun Genomics is a first-of-its-kind, custom probiotics startup with the mission to improve gut health through personalized science. The company's first consumer product, Floré, allows consumers to analyze the microflora of their stool and uses the results to craft a custom probiotic. Through DNA sequencing, Floré formulates the right probiotics for each customer's specific needs and delivers it directly to their door. Sun Genomics has created the first feedback loop to allow customers to see their probiotics show up on their report, through a retest, and allows customers to improve their microflora over time. For more information, visit www.sungenomics.com or follow on Twitter: @SunGenomics. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Orion Fund Investments

3 Investments

Orion Fund has made 3 investments. Their latest investment was in Kanndu as part of their Series A on October 10, 2000.

CBI Logo

Orion Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/1/2000

Series A

Kanndu

$4.5M

Yes

eXseed Fund, and Undisclosed Angel Investors

1

3/1/2000

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/1/1999

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/1/2000

3/1/2000

12/1/1999

Round

Series A

Series A

Series A

Company

Kanndu

Subscribe to see more

Subscribe to see more

Amount

$4.5M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

eXseed Fund, and Undisclosed Angel Investors

Sources

1

10

10

Orion Fund Portfolio Exits

1 Portfolio Exit

Orion Fund has 1 portfolio exit. Their latest portfolio exit was Maximal on June 21, 2001.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/21/2001

Acquired

1

Date

6/21/2001

Exit

Acquired

Companies

Valuation

Acquirer

Sources

1

Orion Fund Fund History

1 Fund History

Orion Fund has 1 fund, including AIG Orion Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

11/1/2002

AIG Orion Fund

Early-Stage Venture Capital

Closed

$70M

1

Closing Date

11/1/2002

Fund

AIG Orion Fund

Fund Type

Early-Stage Venture Capital

Status

Closed

Amount

$70M

Sources

1

Orion Fund Team

5 Team Members

Orion Fund has 5 team members, including current Managing Partner, Eyal Levy.

Name

Work History

Title

Status

Eyal Levy

Managing Partner

Current

Hagai Goldhirsh

Chief Financial Officer

Former

Gabriel Goren

Managing Partner

Former

Yair Sakov

Vertex Venture Capital

Managing Partner

Former

Scott Foushee

PineBridge Investments

Managing Director

Former

Name

Eyal Levy

Hagai Goldhirsh

Gabriel Goren

Yair Sakov

Scott Foushee

Work History

Vertex Venture Capital

PineBridge Investments

Title

Managing Partner

Chief Financial Officer

Managing Partner

Managing Partner

Managing Director

Status

Current

Former

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.